Alterity Therapeutics Ltd. (PRNAF)

Alterity Therapeutics Ltd. (PRNAF) Financial Statements


Alterity Therapeutics Ltd. Financial Overview

Alterity Therapeutics Ltd.'s market cap is currently ―. The company's EPS TTM is $-0.003; its P/E ratio is -6.67; Alterity Therapeutics Ltd. is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Dec 22Jun 22Dec 21Jun 21
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 15.77MAU$ 25.34MAU$ 34.81MAU$ 37.00MAU$ 28.12M
Total AssetsAU$ 27.32MAU$ 33.38MAU$ 41.36MAU$ 44.93MAU$ 33.59M
Total DebtAU$ 210.38KAU$ 0.00AU$ 117.49KAU$ 41.89KAU$ 65.65K
Net DebtAU$ -15.56MAU$ -25.34MAU$ -34.69MAU$ -36.96MAU$ -28.05M
Total LiabilitiesAU$ 4.50MAU$ 5.28MAU$ 5.89MAU$ 3.80MAU$ 3.12M
Stockholders EquityAU$ 22.81MAU$ 28.10MAU$ 35.47MAU$ 41.13MAU$ 30.47M
Cash Flow-
Free Cash Flow-AU$ -5.16MAU$ -72.42KAU$ -3.78MAU$ -17.33M
Operating Cash Flow-----
Investing Cash Flow-AU$ -4.88KAU$ -89.15KAU$ -2.56KAU$ -10.47K
Financing Cash Flow-AU$ -108.90KAU$ -285.44KAU$ -268.97KAU$ 36.65M
Currency in AUD

Alterity Therapeutics Ltd. Earnings and Revenue History

Alterity Therapeutics Ltd. Debt to Assets

Alterity Therapeutics Ltd. Cash Flow

Alterity Therapeutics Ltd. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis